Orexigen (OREX) Higher Again, Shares Now Up ~90% in June Following Arena (ARNA), Analyst Upgrade

Article Stock Quotes (2) Comments (0)

Investors just can't get enough Orexigen Therapeutics (Nasdaq: OREX) following the FDA decision on Arena Pharmaceutircals (Nasdaq: ARNA) lorcaserin Wednesday and JPMorgan upgrade Thursday. Shares are up an additional 7.6 percent Friday, pushing shares up about 90 percent for the month of June.

Stock volatility is up about 2 percent from Thursday's close.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
• China Q1 Online Ad Revs Grow 28% Y/Y Led by Keyword Search (BIDU) (SOHU)
• Investors Brace for Epic Herbalife (HLF) Short Squeeze

Create E-mail Alert Related Categories

Insiders' Blog, Momentum Movers

Related Entities

JPMorgan

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?